Publications by authors named "Ni Ken Ritchie"
Article Synopsis
- This study investigated the effectiveness of Covid Convalescent Plasma (CCP) in hospitalized patients with moderate COVID-19, as its efficacy in severe cases was previously unproven.
- Conducted as a randomized controlled trial in Jakarta, Indonesia, from November 2020 to August 2021, the main goal was to measure mortality rates at 14 days, with secondary outcomes including longer-term mortality and discharge times.
- Results showed no significant reduction in 14-day mortality for CCP versus standard treatment, but the CCP group did have lower mortality rates at 28 days and over the full follow-up period, though these differences weren’t statistically significant.
Background: Children with bleeding disorders, such as hemophilia and von Willebrand disease (VWD), have an increased risk of acquiring transfusion-transmitted infections (TTI). Screening methods to exclude blood donations that are at risk of transmitting infection from donors to recipients are critical to preventing disease transmission. Nucleic acid testing (NAT) is the latest blood donor-screening method.
View Article and Find Full Text PDF